Fifth Third Bancorp »

CanFite Biopharma shares owned by Fifth Third Bancorp

Quarter-by-quarter ownership of CanFite Biopharma (CANF) shares owned by Fifth Third Bancorp from 13F filings

Historical chart of Fifth Third Bancorp investment in CanFite Biopharma

Tip: Access up to 7 years of quarterly data

All positions including CanFite Biopharma held by Fifth Third Bancorp consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in CanFite Biopharma by Fifth Third Bancorp

Quarter filed Position value Share count Share price at filing
2026-03-31 $465 150 3.10

More positions owned by Fifth Third Bancorp

NVIDIA Corporation (NVDA)
Apple (AAPL)
Ishares Tr Core S&p500 Etf (IVV)
Eli Lilly & Co. (LLY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Amazon (AMZN)
Broadcom (AVGO)
JPMorgan Chase & Co. (JPM)
Ishares Tr S&p 100 Etf (OEF)
Meta Platforms Cl A (META)
Alphabet Cap Stk Cl C (GOOG)
State Str Spdr S&p 500 Etf T Tr Unit (SPY)
Exxon Mobil Corporation (XOM)
Ishares Tr Core S&p Mcp Etf (IJH)

View all positions for Fifth Third Bancorp

Top funds holding CanFite Biopharma

Citadel Advisors
Rhumbline Advisers
Hrt Financial
Citigroup
UBS Group
Fifth Third Bancorp
Wells Fargo & Company
Activest Wealth Management
Efficient Wealth Management
Morgan Stanley
TD Waterhouse Canada

View all funds holding CanFite Biopharma